Vect-Horus Overview

  • Founded
  • 2005

Founded
  • Status
  • Private

  • Employees
  • 36

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1M

  • Investors
  • 7

Vect-Horus General Information

Description

Developer of a targeted drug delivery system intended to enhance the transport of biotherapeutics across biological barriers. The company's system is based on the specific design and optimization of molecular vectors that once conjugated to a payload delivered to target cells in the body, enabling healthcare providers to improve therapeutic or diagnostic benefits while minimizing both dose levels and off-target effects of newly developed molecules.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • Faculté de la Timone
  • 27 Boulevard Jean Moulin 1er étage aile Verte
  • 13005 Marseille
  • France
+33 04 00 00 00 00

Vect-Horus Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vect-Horus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 01-Feb-2022 $1M 000.00 Completed Generating Revenue
9. Later Stage VC (Series D) 01-Dec-2020 000.00 000.00 000.00 Completed Generating Revenue
8. Later Stage VC 07-Jun-2018 00.000 000.00 0000 Completed Generating Revenue
7. Later Stage VC 21-Mar-2017 00.000 000.00 0000 Completed Generating Revenue
6. Accelerator/Incubator 00.000 Completed Generating Revenue
5. Angel (individual) 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 15-Dec-2014 00.000 00.000 Completed Generating Revenue
3. Grant 00.000 Completed Startup
2. Later Stage VC 28-May-2013 Completed Startup
1. Later Stage VC 28-May-2011 Completed Startup
To view Vect-Horus’s complete valuation and funding history, request access »

Vect-Horus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view Vect-Horus’s complete cap table history, request access »

Vect-Horus Patents

Vect-Horus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020206593-A1 Transferrin receptor-binding molecules, conjugates thereof and their uses Pending 09-Jan-2019 00000000000
EP-3908608-A1 Transferrin receptor-binding molecules, conjugates thereof and their uses Pending 09-Jan-2019 00000000000
JP-2022518392-A Transferrin receptor binding molecule, its conjugate, and its use Pending 09-Jan-2019 00000000000
CA-3124790-A1 Transferrin receptor-binding molecules, conjugates thereof and their uses Pending 09-Jan-2019 00000000000
US-20220090050-A1 Transferrin receptor-binding molecules, conjugates thereof and their uses Pending 09-Jan-2019 C12N15/1037
To view Vect-Horus’s complete patent history, request access »

Vect-Horus Executive Team (3)

Name Title Board Seat Contact Info
Alexandre Tokay Co-Founder, Chief Executive Officer, & Chairman
Michel Khrestchatisky Ph.D Co-Founder & Scientific Counsel
Jamal Temsamani Ph.D Director, Drug Development & Corporate & Member of the Management Committee
To view Vect-Horus’s complete executive team members history, request access »

Vect-Horus Board Members (1)

Name Representing Role Since
Alexandre Tokay Vect-Horus Co-Founder, Chief Executive Officer, & Chairman 000 0000
To view Vect-Horus’s complete board members history, request access »

Vect-Horus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vect-Horus Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Union Government 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
CAAP Creation Venture Capital Minority 000 0000 000000 0
Financiere Tuileries Corporation Minority 000 0000 000000 0
Alizee Investment Corporation Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »